CHUGAI PHARM UNSP/ADR (CHGCY) analyst actions
Rating and price-target actions on CHGCY in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the CHGCY overview →
No CHGCY analyst action events in the measured window.
Nothing matched in the current window — the CHGCY overview has every event we measure for this name.
Get an email when CHGCY moves on news →Keep exploring
More CHGCY: earnings → · SEC filings → · CHGCY overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| K2 Capital Acquisition Corporation - Class A Ordinary Share (KTWO) | 7 | +0.71% | 100% |
| BlackRock Technology and Private Equity Term Trust Common Shares of Beneficial Interest (BTX) | 6 | +0.12% | 50% |
| GETINGE AB UNSP/ADR (GNGBY) | 6 | -0.03% | 33% |
| INNOVATION PHARMACEUTICAL (IPIX) | 6 | -2.52% | 0% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.